About
Neuraura
Neuraura Biotech Inc., (Neuraura) is a seed-stage medical technology company based out of Calgary, Western Canada, having originally spun out its core micro-electrode technology from the Hotchkiss Brain Institute, a pioneering institution in the field of brain machine interface.
Neuraura shifted its primary focus to LoOoP, a minimally-invasive bioelectronic platform to manage chronic conditions in Q4 2022. LoOoP’s primary clinical use case is polycystic ovary syndrome (PCOS), one of the most common, most overlooked and most underserved women’s health conditions.
Our Impact
Neuraura’s technology addresses unmet needs through brain imaging and minimally-invasive stimulation
Neurological & Mental Health
EEG imaging for epilepsy, Parkinson’s, depression and others
Polycystic Ovarian Syndrome
Hormonal, metabolic and reproductive/menstrual health
Emerging
Applications
Insulin resistance /diabetes; Endometriosis
Our Partnerships
First in-kind biowearable platform for PCOS
Reconnecting with the body's natural rhythm.
LoOoP will be the first effective and accessible solution for PCOS (polycystic ovarian syndrome). LoOoP combines a minimally-invasive bioelectronic to alleviate the symptoms of the condition with a digital platform to reduce the overall burden of disease.
In our LoOoP device we are leveraging our patented micro-electrode technology to translate high quality, peer-reviewed findings that demonstrate that electrostimulation reduces circulating glucose, shifts the baseline metabolism, improves menstrual regularity and increases ovarian blood flow.
Our broader LoOoP platform will provide an end-to-end solution to support women throughout their lifetime journey with PCOS, integrating personalized insights and recommendations, curated content and complementary clinical and wellness solutions.
Our longer team vision is to use real-world evidence and AI analytics to advance the field of knowledge in PCOS and related health complications.
